Key Points {#sec1}
==========

1.The landscape of ever evolving information about COVID-19 during the pandemic has hindered the transition to normal clinical volume and efficiency.2.COVID-19 should not be a reason for delay in diagnosis or treatment with patients who have upper aerodigestive tract pathology or malignancy.3.The approach to resection, reconstruction, and surveillance for patients with head and neck cancer may need to be altered to consider severity of disease, patient co-morbidity, and prevalence of regional COVID-19 infections, amongst other factors.4.In light of the significant number of prolonged intubations, there may be an increase in the number of patients who develop early- and late- sequelae of treatment for COVID-19. Tracheostomy should be performed in a safe and efficient manner when specific indications are met.

Introduction/History/Definitions/Background {#sec2}
===========================================

The downstream effects of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have now pervaded most aspects of society, and have made an indelible mark on the way that medicine, and specifically, otolaryngology, is being practiced. Of note, the disease represents a threat to an aging population throughout the world [@bib1], but also has dangerous implications for providers [@bib2], [@bib3], [@bib4]. Among the most "at-risk" group" of medical providers may be those within the fields of otolaryngology [@bib5] and ophthalmology. An otolaryngologist was among one of the first providers to succumb to the illness in its early days as it spread through Wuhan, China [@bib4]. In light of the risk to both patients, health-care workers, and society at-large, a push has been made to mitigate the risk of transmission within the field of Otolaryngology Head and Neck Surgery.

As of June 22^nd^, 2020, there are a total of 9,135,510 COVID-19 cases reported worldwide, with a total of 472,322 deaths [@bib6]. The United States has the highest number of cases at 2,377,026, with the total number dead at 122,526. Given the high mortality associated with the novel virus, much of the world has enacted significant social distancing restrictions and facial covering mandates to curb the spread of the disease. The origin of the virus is not well understood, but it is thought that a bat or pangolin vector might have served as the primary reservoir [@bib7]. The disease tends to be marked by fever (43-98% of patients) and cough (68-82% of patients) [@bib1], however a litany of other symptoms have also been described including gastrointestinal upset, diarrhea, shortness of breath, headache, loss of smell/taste, among others. Severe disease is characterized by an acute respiratory distress syndrome (ARDS), with a 50-80% mortality for patients that require mechanical ventilation [@bib8] ^,^ [@bib9]. The disease has a slight male predominance at 58.1%. Severity of disease seems to correlate to age, as patients who are aged 1-9 have a mortality \<0.1%, while those over 80 present with a mortality approaching 15% in early studies [@bib1].

The nasal cavity and nasopharynx seem to harbor the highest viral load concentration [@bib10], and thus the nasopharynx is the preferred location for acquisition of samples for diagnostic testing. Nasal swabs, oropharyngeal swabs, bronchial alveolar lavage, saliva, and tracheal aspirates have also been suggested as possible testing sites [@bib11]. The current preferred diagnostic assay is RT-PCR, which has a variable sensitivity of 60-97% depending on the institution and type of test [@bib11].

During the months of May and June 2020, many cities, states, and countries have focused on a return to normal activity and a ramp up of commercial activities. During this time, many otolaryngology practices have aimed to ramp up activity as well while employing telehealth, social distancing, and utilization of personal protective equipment (PPE). The American Academy of Otolaryngology recently published return to practice guidelines, which are detailed below [@bib12]. As the world continues to move forward during the COVID-19 era, considerations such as testing, including pre-operative/pre-procedure COVID testing, surgical triage, clinic workflow, and practice management continue to evolve as more information becomes available. This review is intended to highlight some of the current recommendations for patient care within the Laryngology and Head and Neck Surgical Oncology scope of practice.

Discussion {#sec3}
==========

Laryngology {#sec3.1}
-----------

As cases continue to rise, increased emphasis has been placed on protection for the provider in the clinical setting. Over the last decade, office-based management of many common laryngeal disorders has significantly expanded [@bib13]. This includes, but is not limited to, office-based laser ablation of papilloma or dysplasia, transoral or transcervical injection laryngoplasty for vocal fold paralysis, and EMG-guided injection of Botox for spasmodic dysphonia. Given the high number of clinic-based aerosol-generating procedures practiced by today's laryngologists, many providers have seen a marked reduction in their ability to treat patients and their clinical productivity. Within the category of aerosol-generating procedures is flexible fiberoptic laryngoscopy, one of the most widely used diagnostic tools for all otolaryngologists and speech pathologists.

A consensus statement reported by Rameau et al from a virtual webinar attended by approximately 300 participants in the American laryngology community recommended flexible laryngoscopy should be reserved for critical cases in which the findings may have an immediate impact on diagnosis or treatment. "Indications include hemoptysis, odynophagia limiting hydration and nutrition, or airway compromise---notably secondary to infectious and malignant conditions." [@bib14] Some have advocated for pre-clinic COVID testing prior to any aerosol generating procedure [@bib4] ^,^ [@bib14], however given the high false negative rate of many available tests the use of universal personal protective precautions is recommended. According to Givi and colleagues, examinations should take place in negative pressure rooms if possible [@bib5], with avoidance of topical lidocaine spray although other groups recommend administration of a topical anesthetic to theoretically decrease the cough/sneeze reflex (unpublished on-line chats). A substitute to standard aerosolized anesthesia may be pledgets soaked in 4% lidocaine and 0.05% oxymetazoline. The group also suggests using videolaryngoscopy whenever possible to keep the practitioner and the patient farther apart. Disposable laryngoscopes should be used whenever possible [@bib5]. Most studies universally recommend the following personal protective equipment (PPE): N95 mask or powered air-purifying respirators (PAPRs), gloves, gown, eye shield (or goggles), and cap [@bib1] ^,^ [@bib5] ^,^ [@bib11] ^,^ [@bib15] ^,^ [@bib16]. It has also been suggested that the patients wear a mask covering the mouth during flexible laryngoscopy to reduce aerosolization from phonatory maneuvers and in case of coughing or sneezing. At this time, transoral rigid and mirror laryngoscopy are discouraged unless flexible laryngoscopy cannot be performed due to the increased risk of gagging and coughing, as well as the need for the patient to phonate with the mouth uncovered to allow visualization of the larynx. Additionally, universal masking is encouraged in all clinical spaces, in accordance with many state policies. Patients in the waiting rooms are encouraged to physically distance or wait in their car for a phone call prior to presenting for their appointment. Crosby also suggests offering personal protective equipment for the friends and family accompanying the patient during laryngoscopy [@bib17], and other sites prevent friends and family from accompanying patients inside for the visit. Some alternatives to flexible laryngoscopy have been raised, including transcervical laryngeal ultrasound, which has a reported concordance of 70-95% in identifying vocal fold motion abnormalities [@bib18].

Another key consideration for the laryngologist in the COVID-19 era is the approach to sanitization and room turnover after aerosol generating procedures (AGPs). Laryngoscope turnover should include high-level disinfection, including the use of such chemical disinfectants as glutaraldehyde, chlorine dioxide, or ortho-phthaladehyde (OPA) [@bib14]. Some authors recommend immediate placement of the scope after use into a covered receptacle for transport from the examination room to the sterile processing areas [@bib17]. After completion of laryngoscopy, room sanitization with an EPA-registered, hospital-grade disinfectant is recommended with a 2-3% hydrogen peroxide solution, 2-5 g/L chlorine disinfectant, or 75% alcohol [@bib19]. According to the CDC website, it is unknown how long the air inside a particular examination room remains infectious and likely relates to the room size, rapidity of air exchange, patient factors (like viral shedding), amount of coughing/sneezing, and length of time patient was in the room [@bib20]. The CDC suggests that rooms with 50 air changes/hour (ACH) take about 6 and 8 minutes to purify the air with 99% and 99.9% efficiency, respectively. As the number of air changes/hour decreases, the time between patients should be increased to allow for appropriate dissipation of theoretical infectious agents. As such, many hospitals have recommended a turnover time of 4x the time it takes to purify the air with 99% efficiency, which may be either 20 minutes or 40 minutes depending on the level of air turnover, or could be no additional time if any additional HEPA filtration system and negative pressure has been added. Limited data exists to support this approach for SARS-CoV-2.

Laryngology patients are quite diverse with respect to their level of acuity. Some patients require more urgent intervention, while others may have their care deferred[@bib12] ^,^ [@bib21]. Most guidelines advocate for a tiered approach to ramping up both clinic-based and surgical activity. The American Academy of Otolaryngology published guidelines for ramping up clinical activity on May 15, 2020. The AAO recommends limiting patient care to individuals with "time-sensitive-urgent and emergent medical conditions."[@bib12] This approach is also echoed in the care of head and neck cancer patients (see below). According to the guidelines, emergent conditions include "impending airway obstruction due to infection, neoplasm, stenosis, foreign body", which may warrant the following intervention: "flexible and rigid laryngoscopy with intervention, direct laryngoscopy/suspension laryngoscopy, bronchoscopy, and tracheostomy". Urgent conditions include "moderate or impending airway obstruction, progressive dysphonia, progressive dysphagia, glottic incompetence causing aspiration or impaired pulmonary toilet", which warrant the previously described procedures in addition to "stroboscopy, functional endoscopic evaluation of swallow, esophagoscopy with or without intervention, open airway procedures for cancer". Time sensitive conditions include "T1 glottic carcinoma or carcinoma in situ, stable/mild dysphonia, stable dysphagia", which adds "transcervical Botox injection" to the above list of procedures. Routine conditions which may be deferred for 90 days or more include "mild/moderate dysplasia, non-obstructive benign/phonotraumatic lesions of the vocal folds, glottic incompetence, glottic incompetence with mild to moderate dysphonia, gender affirmation, globus/cough without alarm signs." Comparing acuity of patients also raises an important point about the subset of patients who are typically seen for benign, phonotraumatic voice disorders. Many live vocal performance venues have shut down, concerts have been cancelled or postponed, and some studies point to live singing as being a potential source of massive spread [@bib22], [@bib23], [@bib24]. For this reason, one might assume that the percentage of patients being seen for acute phonotraumatic voice disorders diminishes somewhat. Conversely, as patients continue to recover from hospitalizations related to COVID-19, it is anticipated that there may be a number of patients with sequelae of prolonged intubation including posterior glottic stenosis, vocal fold granulomas, and tracheal/subglottic stenosis.

Laryngeal surgery in the era of COVID has had to undergo some significant changes in the approach to patient triage, surgical technique, and management of the airway. Pre-operative evaluation of patients must weigh the risk of delaying surgery with the risk of complications related to COVID-19 infection. Lei et al studied a group of 34 operative patients, in whom all were COVID-19 positive within the incubation period. Mortality was 20.5% for this group and 44.1% required ICU admission[@bib25]. Of note, all patients in this study underwent surgery about 4 days prior to demonstrating signs or symptoms of COVID-19 pneumonia. This suggests there is significant risk associated with elective surgery in seemingly asymptomatic patients who are infected with COVID-19. For this reason, many authors have suggested pre-operative COVID-19 testing [@bib15] ^,^ [@bib26], [@bib27], [@bib28], although it is a subject of some debate. Some advocate for a negative test within 48 hours followed by self-quarantine until the time of surgery, while others favor a negative test 48hrs from the time of surgery, and a point of care negative test on the day of surgery[@bib17]. This is not always possible, given the limitations of the institution where the patient is undergoing surgery. Just as discussed earlier with regard to personal protective equipment in clinic, universal precautions should be taken including full PPE and all patients should be presumed positive.

Airway management in the COVID-19 era has become a point of focus for quality improvement and safety groups. Endotracheal intubation is cited as one of the procedures which seems to have the highest aerosol generating burden [@bib1] ^,^ [@bib2] ^,^ [@bib5]. It is recommended that intubation be performed by the most experienced practitioner. Additionally, some recommend early intubation for patients that are high risk for decompensation [@bib2], while others have advocated delaying intubation in favor of non-invasive means of ventilation. This may include high flow nasal cannula, which actually has minimal dispersion of exhaled air if appropriately fitted according to Cheung [@bib2] ^,^ [@bib29]. It is recommended that flexible fiberoptic intubation be avoided whenever possible [@bib30]. Additionally, excessive bag-mask ventilation should be avoided due to the risk of dispersion of exhaled air. Furthermore, jet ventilation is considered particularly high risk and should be avoided if possible [@bib5].

Management of the surgical airway and the topic of tracheostomy has been well represented in the recent literature. During the SARS outbreak in 2003, open tracheostomy was the most common surgical procedure performed on infected patients [@bib31]. Most studies seem to favor open tracheostomy over percutaneous tracheostomy [@bib31], however consideration may be given for percutaneous dilatation tracheostomy in some patients if the anatomy is favorable and the practitioner has sufficient expertise with the procedure. Tay and colleagues advocate for use of PAPR during tracheostomy based on the experience of 5 countries during the SARS crisis ^31\ 1^. Other authors [@bib32] have suggested the use of an N95 mask, appropriate eye protection, gown, double gloves, and cap [@bib17] ^,^ [@bib26]. To decrease the risk of auto-contamination, some have recommended an infection control nurse be available to monitor donning and doffing procedures during tracheostomy [@bib31]. Additional proposals include trach teams, which may consist of a surgeon, anesthetist, and scrub nurse to increase efficiency and create an environment of consistent verbal and non-verbal communication (especially important given the burdens of communicating through a mask or PAPR). Portugal et al, discuss a surgical safety checklist for performing tracheostomy in patients with COVID-19^32^. This includes performing tracheostomy in the ICU whenever possible, decreasing the number of personnel in the room, and having a specific tracheostomy bundle in the ICU room to decrease the number of times providers and nurses need to break scrub to leave the room. They also recommend donning inner gloves prior to gown and outer gloves after donning gown to maintain clean inner gloves for the removal and disposal of the rest of the PPE. Two universally agreed upon maneuvers include stopping ventilation prior to entrance into the airway and holding ventilation until after the tracheostomy tube cuff has been inflated. Givi and colleagues suggest that a smaller tracheotomy (6.0 cuffed) may be preferred to decrease the spread of aerosolized particles. Miles discusses the New York experience suggesting that for intubated patients the cuff pressure should be checked every 4 hours, with a goal of 30 cm H2O (greater pressure predisposes tracheal pressure necrosis)[@bib33]. The group also suggests delaying the timing of tracheostomy until 21 days after onset of symptoms when feasible. Finally, some have advocated for the use of specific air containment setups, including plastic draping, smoke evacuator tubing, or specifically designed negative pressure box [@bib15] ^,^ [@bib34], [@bib35], [@bib36].

The field of laryngology has had to undergo significant change in the setting of the COVID 19 pandemic. As the numbers of COVID-19 patients have continued to increase during the month of June, it is clear that practice of laryngology in the post-COVID era will need to be carefully ramped up to protect patients and providers alike. Additionally, one would expect a continued increase in the number of recovered patients being seen for sequelae of prolonged intubation. Decisions to relax restrictions on flexible laryngoscopy and other AGPs will depend on the local incidence of COVID-19 infection, availability and accuracy of pre-procedure testing, sustainable supply of PPE, the ability to properly sanitize rooms, and ultimately, development of an effective vaccine.

Head and Neck Surgical Oncology {#sec3.2}
-------------------------------

Similar to laryngology, the approach to head and neck surgical oncology continues to evolve as more information becomes available during the COVID era. During the early weeks of the pandemic, the aspect of cancer care most concerning to patients and providers involved potential delays in therapy. Finley suggests that delaying cancer surgery should be done with extreme caution despite COVID-19^37^. Additionally, delays beyond 6 weeks could significantly affect long-term outcomes and morbidity of treatment. Among patients diagnosed with severe COVID-19 requiring ICU admission, patients with cancer deteriorated faster than non-cancer patients [@bib8]. Desai and colleagues discovered a higher risk of severe events in patients recently treated with chemotherapy or surgery in the past 30 days compared to non-cancer COVID-16 patients[@bib38]. Additionally, patients with advanced stage cancer tended to have a higher rate of severe events when compared to early stage cancer. Cancer patients undergoing active treatment are predisposed to COVID-19 related complications, and critically ill patients with cancer have a higher predisposition to death [@bib9].

Head and neck cancer patients, especially, are considered a high-risk population for complications associated with COVID-19 infection[@bib8], making safe coordination of care difficult but imperative. Head and neck cancer patients are an at-risk group for a number of reasons. Silverman points out that head and neck cancer patients tend to present with advanced age, history of tobacco and alcohol abuse, and cardiac and pulmonary comorbidities, which are similarly found in COVID-19 ^39^. Risk of respiratory sequelae in patients who have received chemotherapy and/or radiation therapy are high, with increased rates of dysphagia, aspiration, and pneumonia. Additionally, head and neck cancer patients have an increased risk of respiratory infections and aspiration pneumonitis [@bib39]. These factors may expedite deterioration to severe adverse events in patients with COVID-19. Additionally, head and neck patients who are actively receiving chemotherapy or immunotherapy may have depressed immune function, malnutrition, and older age. For this reason, the patients need to be carefully selected and co-morbidities strongly considered when constructing a treatment plan for patients with head and neck cancer.

Within the United States, mortality for patients of color (African American and Latinx) with COVID-19 is significantly higher than for Caucasian patients[@bib40]. Unfortunately, this is a consequence of inequality within society and the healthcare system, rather than a biological or pathological difference.[@bib41] Correspondingly, these communities also tend to present with more advanced disease and have significantly worse mortality compared to their Caucasian fellow citizens. This pandemic has laid to bear some of the gross inequities within the American health care system and highlighted the need for equitable decision making for all patients with a diagnosis of head and neck cancer during the COVID-19 era.

Another consideration for the head and neck cancer patient during the COVID-19 era, may include the financial burden and cost of survivorship associated with undergoing cancer treatment and financial hardship related to COVID-19's effect on the world economy and increasing levels of unemployment [@bib41] ^,^ [@bib42]. Given the significant job losses across the United States, there is preliminary data to suggest that there will be at least 1.55 million newly unemployed people who will also lose their insurance coverage in the wake of the pandemic [@bib43]. Increased financial strain has been associated with decreased quality of life scores and subsequently mortality in head and neck cancer patients [@bib44], [@bib45], [@bib46], [@bib47], [@bib48].

Recommendations for head and neck clinic are similar to what was previously discussed for laryngology. Providers are expected to take universal precautions, regardless of the patient's COVID status. Flexible fiberoptic laryngoscopy is considered a high-risk aerosol generating procedure. Due to this, laryngoscopy should be reserved for instances in which it is likely to change management. One of the beneficial consequences of the COVID-19 era is the increased access of care through the widespread adoption of telehealth clinics among most hospitals[@bib49]. Providers may use telemedicine as an initial pre-operative assessment or pre-screen for patients that will later be seen in clinic or prior to surgery. While telehealth is wonderful for obtaining a detailed history, reviewing data/imaging/labs, and discussing surgical options/risks/benefits, a big drawback is the inability to perform a comprehensive head and neck physical exam [@bib26]. Physical examination, with or without fiberoptic laryngoscopy, is important to define the extent of tumor and formulating an ablative and reconstructive plan. Fortunately, some work-arounds include anatomic and physiologic imaging for ablative planning and CT angiography and virtual planning sessions for microvascular reconstruction. Telemedicine also serves a vital role in triage of post-treatment head and neck cancer patients who may not be able to be seen as frequently due to the pandemic [@bib5] ^,^ [@bib12].

Telemedicine also serves a vital role in the coordination of care between multiple oncologic disciplines. Dharmarajan and colleagues highlighted the University of Pittsburgh approach to a virtual multidisciplinary tumor board clinic (MDC). This strategy has been adopted by multiple institutions, and works quite well to coordinate care between specialties. In their study, they found that 57.9% of virtual tumor board participants preferred virtual multidisciplinary clinic to the in-person format. Additionally, about 78.9% of participants indicated that they would prefer to continue the virtual multidisciplinary format once in person meeting restrictions had been lifted. Through multiple virtual meeting applications, practitioners can share imaging and laryngoscopy which may assist with decision making for patients.

Similar to the guidelines published for laryngeal surgery, the American Academy of Otolaryngology has published recommendations for ramping up clinical volume as it relates to triage for head and neck surgical oncology. Setzen et al note that most head and neck cases fall within the urgent category. The guidelines list emergent procedures as being tumor obstructing airway, significant bleeding, acute or impending neurological change, and salivary gland or deep neck abscesses. Urgent procedures (within 30 days) include all head and neck squamous cell carcinomas of the upper aerodigestive tract, benign tumors with impending complications or morbidity, anaplastic thyroid cancer, medullary thyroid cancer, bulky differentiated thyroid cancer with regional/distant metastasis, locally aggressive, or large nodules (\>4cm Bethesda 3,4,5,6), high grade salivary malignancies, skin cancers, and parathyroid carcinomas with significant systemic effects. Time sensitive procedures include low-risk differentiated thyroid cancer, low-grade salivary neoplasms, and slower growing basal cell carcinomas in favorable locations. Routine procedures include benign thyroid pathology, parathyroid disease without significant systemic effects, benign salivary lesions, and low risk skin cancers, and post-treatment disorders. Ranasinghe and colleagues recommend a tiered approach to surgical triage, with more aggressive pathology being prioritized in a similar fashion to the AAO guidelines [@bib26]. Similarly, the review recommends considering alternatives to long-duration microvascular reconstructive cases. It is recommended that the focus shift to simplifying reconstruction and reducing surgical duration, when it's feasible and appropriate. However, it is also acknowledged that this approach may lead to an increase in downstream complications. Endocrine surgery is similarly tiered in a memo by Ashok Shaha, which outlines a strategic approach to thyroid surgery during the pandemic. Similar to other strategies, anaplastic thyroid cancer, medullary thyroid cancer, and locally aggressive differentiated thyroid cancer, specifically with impending concern for airway obstruction take precedent [@bib50]. However, some alternatives are also discussed, for instance, in patients with BRAF V600E mutations, who may have surgery delayed while being treated with appropriate targeted therapies. Additionally, de-escalation of surgical care is advocated for benign conditions like thyroid goiters that are non-obstructive, and even papillary thyroid microcarcinoma (which may be followed with serial ultrasonography until resource allocation has returned to pre-COVID levels).

As institutions attempt to weigh the pros and cons of elective and essential surgery in the midst of the pandemic, some authors have advocated for creating rating systems to allow for appropriate surgical triage during periods of limited clinical output and resource re-allocation. The medically necessary, time-sensitive (MeNTS) procedures scoring system aims to "ethically and efficiently manage resource re-allocation and risk to healthcare providers" during the COVID-19 pandemic[@bib51]. The scoring system, which uses procedural, disease, and patient factors within a 5-point Likert scale to determine the potential risk of proceeding with surgery. The cumulative MeNTS score may range between 21 and 105, with score above 64 being considered within the high risk or resource heavy procedures, either due to patient factors (Age/Co-morbidities) or procedure factors (head and neck surgical site, high anticipated blood loss, ICU admission requirement.). Using scoring systems like MeNTS should help hospitals more appropriately and objectively triage elective and essential surgeries in the setting of a resurgence of cases/limiting of resources.

Given the significant lack of available knowledge regarding SARS-CoV2 and its associated complications, it is difficult to characterize risk for patients undergoing ablative and reconstructive head and neck surgery. As mentioned earlier, in asymptomatic COVID-19 positive patients undergoing elective surgery, mortality approached 20% [@bib25]. COVID-19 has demonstrated myriad manifestations which might interfere with the success and management of patients undergoing head and neck surgery. Tang demonstrated that coagulopathy was more common in patients with severe disease, and non-surviving COVID patients[@bib52]. In this study, D-dimer, fibrin degradation products, prothrombin time, and partial thromboplastin time were all significantly increased in non-surviving patients relative to those surviving COVID-19^53^. Additional studies demonstrate a prothrombotic state in certain patients, with 7 of 12 patients having deep venous thromboses on autopsy[@bib54]. The mechanisms of this COVID-related coagulopathy are not yet well-described in the literature; however, these undefined entities pose certain risk for reconstructive efforts in patients with head and neck cancer.

In lieu of significant surgical delays, radiation +/- chemotherapy may be considered for certain patients. However, administration of chemotherapy and fractionated radiotherapy requires multiple trips to hospitals[@bib55]. This can potentially expose patients, who are already considered high risk, to SARS-CoV2. Sharma and colleagues stress the importance of making informed decisions, weighing not only the patient, comorbidities, and disease status, but also the prevalence of COVID and resource availability when making decisions about preferred options for treatment.

Summary {#sec4}
=======

COVID-19 has forever changed the way that otolaryngologists approach laryngology and head and neck cancer care. Telemedicine has become an effective tool for the work up of disease and interface with patients remotely. Flexible laryngoscopy should be reserved for urgent/time-sensitive cases, in which it will have a direct impact on management. Attempts should be made by all providers to ensure that appropriate personal protective equipment is worn and that universal precautions are taken for every patient, regardless of COVID-19 status. Given the high false negative rate associated with nasopharyngeal RT-PCR, the role of pre-clinical or pre-operative COVID testing has yet to be rigorously evaluated. Given the high mortality associated with elective surgery in asymptomatic COVID-19 patients, however, pre-operative COVID testing is the best available option for triage of asymptomatic patients. Surgical decisions making should involve both the provider and the patient in a discussion about the necessity of surgery and other alternatives available in the context of the local COVID-19 landscape. Specific tools, like the MeNTS score, may be helpful to risk stratify these patients and inform these decisions.
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